Expertise in
4
conditions

Thomas Ruhstaller

Basel, BS, CH 
Expertise in
4
conditions
Basel, BS, CH 

Overview

Thomas Ruhstaller practices practicing medicine in Basel, Switzerland.

Mr. Ruhstaller is highly rated in 4 conditions, according to our data. His clinical expertise encompasses Breast Cancer, HER-2 Positive Breast Cancer, Esophageal Cancer, Menopause, and Mastectomy.

He is actively involved in clinical research, co-authoring 63 peer reviewed articles and participating in 2 clinical trials.

Gender

Male

Locations

Basel, BS, Switzerland
Other Locations
Bern, BE, Switzerland
St Gallen, Switzerland
Sankt Gallen, SG, Switzerland
Kantonsspital Winterthur
Winterthur, ZH, Switzerland
Kantonsspital Graubünden
Chur, GR, Switzerland

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

eMonarcHER: A Randomized, Double Blind, Placebo-Controlled Phase 3 Study of Abemaciclib Plus Standard Adjuvant Endocrine Therapy in Participants With High-Risk, Node-Positive, HR+, HER2+ Early Breast Cancer Who Have Completed Adjuvant HER2-Targeted Therapy
eMonarcHER: A Randomized, Double Blind, Placebo-Controlled Phase 3 Study of Abemaciclib Plus Standard Adjuvant Endocrine Therapy in Participants With High-Risk, Node-Positive, HR+, HER2+ Early Breast Cancer Who Have Completed Adjuvant HER2-Targeted Therapy
Enrollment Status: Terminated
Publish Date: July 15, 2025
Intervention Type: Drug
Study Drugs: Abemaciclib, Standard Adjuvant Endocrine Therapy
Study Phase: Phase 3
Ribociclib-endocrine Combination Therapy Versus Chemotherapy as 1st Line Treatment in Patients With Visceral Metastatic Breast Cancer. A Multicenter, Randomized Phase III Trial.
Ribociclib-endocrine Combination Therapy Versus Chemotherapy as 1st Line Treatment in Patients With Visceral Metastatic Breast Cancer. A Multicenter, Randomized Phase III Trial.
Enrollment Status: Terminated
Publish Date: June 16, 2021
Intervention Type: Other, Drug
Study Drug: Ribociclib
Study Phase: Phase 3
View 1 Less Clinical Trial

63 Total Publications

Final outcomes of the SOFT and TEXT phase III trials in premenopausal hormone receptor-positive early breast cancer.
Final outcomes of the SOFT and TEXT phase III trials in premenopausal hormone receptor-positive early breast cancer.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: April 16, 2026

Frequently Asked Questions about Thomas Ruhstaller

Is Thomas Ruhstaller a top-rated expert for Breast Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Thomas Ruhstaller is classified as an Advanced expert for Breast Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Thomas Ruhstaller participate in research or clinical trials?

Yes. Thomas Ruhstaller has published 63 articles and abstracts on conditions like Breast Cancer. You can view a list of Thomas Ruhstaller's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Ruhstaller's expertise for a condition
ConditionClose
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile